Chloe L. Rackham

1.2k total citations
20 papers, 951 citations indexed

About

Chloe L. Rackham is a scholar working on Surgery, Genetics and Genetics. According to data from OpenAlex, Chloe L. Rackham has authored 20 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 9 papers in Genetics and 9 papers in Genetics. Recurrent topics in Chloe L. Rackham's work include Pancreatic function and diabetes (18 papers), Mesenchymal stem cell research (9 papers) and Diabetes and associated disorders (7 papers). Chloe L. Rackham is often cited by papers focused on Pancreatic function and diabetes (18 papers), Mesenchymal stem cell research (9 papers) and Diabetes and associated disorders (7 papers). Chloe L. Rackham collaborates with scholars based in United Kingdom, Brazil and Netherlands. Chloe L. Rackham's co-authors include Peter M. Jones, Aileen King, Pedro César Chagastelles, Richard J. Ellis, Paramjeet K. Dhadda, Mark Peakman, Timothy Tree, Colin Dayan, Jennifer S. Allen and Ania Skowera and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Diabetes.

In The Last Decade

Chloe L. Rackham

20 papers receiving 945 citations

Peers

Chloe L. Rackham
Ming Yu United States
Jo Anna Reems United States
Jung-Sik Kim South Korea
Dan Zekzer United States
Il‐Hee Yoon South Korea
Guliang Xia United States
J Primo France
B J Miller United States
Maryam Yousefi United States
Ming Yu United States
Chloe L. Rackham
Citations per year, relative to Chloe L. Rackham Chloe L. Rackham (= 1×) peers Ming Yu

Countries citing papers authored by Chloe L. Rackham

Since Specialization
Citations

This map shows the geographic impact of Chloe L. Rackham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe L. Rackham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe L. Rackham more than expected).

Fields of papers citing papers by Chloe L. Rackham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe L. Rackham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe L. Rackham. The network helps show where Chloe L. Rackham may publish in the future.

Co-authorship network of co-authors of Chloe L. Rackham

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe L. Rackham. A scholar is included among the top collaborators of Chloe L. Rackham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe L. Rackham. Chloe L. Rackham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Sarah J., et al.. (2024). Mesenchymal stromal cells and their secretory products reduce the inflammatory crosstalk between islets and endothelial cells. Endocrine. 87(1). 94–105. 1 indexed citations
2.
Caxaria, Sara, Sufyan Hussain, Min Zhao, et al.. (2023). Mesenchymal stromal cell secretory molecules improve the functional survival of human islets. Diabetic Medicine. 40(12). e15227–e15227. 2 indexed citations
3.
Gribben, Christopher, Christopher Lambert, Hendrik A. Messal, et al.. (2021). Ductal Ngn3-expressing progenitors contribute to adult β cell neogenesis in the pancreas. Cell stem cell. 28(11). 2000–2008.e4. 54 indexed citations
4.
Rackham, Chloe L., et al.. (2021). Protecting islet functional viability using mesenchymal stromal cells. Stem Cells Translational Medicine. 10(5). 674–680. 28 indexed citations
5.
Rackham, Chloe L., et al.. (2020). Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer. Stem Cells. 38(4). 574–584. 46 indexed citations
6.
Dhadda, Paramjeet K., et al.. (2019). Characterization of the Effects of Mesenchymal Stromal Cells on Mouse and Human Islet Function. Stem Cells Translational Medicine. 8(9). 935–944. 19 indexed citations
7.
Rackham, Chloe L. & Peter M. Jones. (2018). Potential of mesenchymal stromal cells for improving islet transplantation outcomes. Current Opinion in Pharmacology. 43. 34–39. 13 indexed citations
8.
Rackham, Chloe L., Stefan Amisten, Shanta J. Persaud, Aileen King, & Peter M. Jones. (2018). Mesenchymal stromal cell secretory factors induce sustained improvements in islet function pre- and post-transplantation. Cytotherapy. 20(12). 1427–1436. 25 indexed citations
9.
Rackham, Chloe L., et al.. (2018). Composite Mesenchymal Stromal Cell Islets: Implications for Transplantation via the Clinically Preferred Intraportal Route. Transplantation Direct. 4(4). e354–e354. 5 indexed citations
10.
Rackham, Chloe L., Paramjeet K. Dhadda, Pratik Choudhary, et al.. (2017). Mesenchymal stromal cells improve human islet function through released products and extracellular matrix. Clinical Science. 131(23). 2835–2845. 54 indexed citations
11.
Rackham, Chloe L., Andréia Escosteguy Vargas, Stefan Amisten, et al.. (2015). Annexin A1 Is a Key Modulator of Mesenchymal Stromal Cell–Mediated Improvements in Islet Function. Diabetes. 65(1). 129–139. 59 indexed citations
13.
Moreau, Aurélie, Jian‐Guo Chai, Kulachelvy Ratnasothy, et al.. (2014). Transitional‐2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival. European Journal of Immunology. 45(3). 843–853. 39 indexed citations
14.
Rackham, Chloe L., Paramjeet K. Dhadda, Pedro César Chagastelles, et al.. (2013). Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice. Cytotherapy. 15(4). 449–459. 62 indexed citations
15.
Rackham, Chloe L., Peter M. Jones, & Aileen King. (2013). Maintenance of Islet Morphology Is Beneficial for Transplantation Outcome in Diabetic Mice. PLoS ONE. 8(2). e57844–e57844. 22 indexed citations
16.
Rackham, Chloe L., Pedro César Chagastelles, Nance Beyer Nardi, et al.. (2011). Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia. 54(5). 1127–1135. 103 indexed citations
17.
Skowera, Ania, Richard J. Ellis, Rubén Varela‐Calviño, et al.. (2009). CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. Journal of Clinical Investigation. 119(9). 2844–2844. 3 indexed citations
18.
Skowera, Ania, Richard J. Ellis, Rubén Varela‐Calviño, et al.. (2009). CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. Journal of Clinical Investigation. 119(9). 2843–2843. 1 indexed citations
19.
Skowera, Ania, Richard J. Ellis, Rubén Varela‐Calviño, et al.. (2008). CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. Journal of Clinical Investigation. 118(10). 3390–402. 298 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026